UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

SCHEDULE 13G

 

Under the Securities Exchange Act of 1934

 

OptimizeRx Corporation

(Name of Issuer)

 

Common Stock

(Title of Class of Securities)

 

68401U204

(CUSIP Number)

 

October 24, 2023

(Date of Event Which Requires Filing of this Statement)

 

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

 

Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)

 

*The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

 

The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

 

 

 

 

 

 

CUSIP NO.  68401U204 Schedule 13G Page 2 of 5

 

1

NAMES OF REPORTING PERSONS

 

Michael Weintraub

2

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)

 

 

(a)     ☐
(b)     ☐
3

SEC USE ONLY

 

 

4

CITIZENSHIP OR PLACE OF ORGANIZATION

 

United States of America

NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON WITH:

5

SOLE VOTING POWER

 

1,384,467

6

SHARED VOTING POWER

 

0

7

SOLE DISPOSITIVE POWER

 

1,384,467

8

SHARED DISPOSITIVE POWER

 

0

9

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

 

1,384,467

10

CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)     

 

 

11

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

  

7.6%

12

TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)

 

IN

 

 

 

 

Page 3 of 5

 

Item 1(a)Name of Issuer:

 

OptimizeRx Corporation (the “Issuer”)

 

Item 1(b)Address of Issuer’s Principal Executive Offices:

 

260 Charles Street, Suite 302, Waltham, MA 02453

 

Item 2(a)Name of Person Filing:

 

Michael Weintraub (the “Reporting Person”)

 

Item 2(b)Address of Principal Business Office or, if none, Residence:

 

10799 N 90th Street, Suite 200

Scottsdale, AZ 85260

 

Item 2(c)Citizenship:

 

United States of America

 

Item 2(d)Title of Class of Securities:

 

Common Stock, par value $0.001 per share (“Common Stock”)

 

Item 2(e)CUSIP Number:

 

68401U204

 

Item 3Not Applicable

 

Item 4Ownership:

 

The following describes the ownership of Common Stock by the Reporting Person as of October 24, 2023:

 

(a)Amount beneficially owned: 1,384,467 shares of Common Stock.

 

The filing of this Schedule 13G shall not be construed as an admission that (a) the Reporting Person is, for purposes of Section 13(d) or 13(g) of the Act, the beneficial owner of any equity securities covered by this Schedule 13G or (b) that this Schedule 13G is legally required to be filed by the Reporting Person.

 

(b)Percent of class: 7.6% (based on 18,148,829 shares of Common Stock outstanding as of October 24, 2023)

 

 

 

 

Page 4 of 5

 

(c)Number of shares as to which the Reporting Person has:

 

(i)sole power to vote or to direct the vote: 1,384,467

 

(ii)shared power to vote or to direct the vote: 0

 

(iii)sole power to dispose or to direct the disposition of: 1,384,467

 

(iv)shared power to dispose or to direct the disposition of: 0

 

Item 5Ownership of Five Percent or Less of a Class:

 

Not Applicable

 

Item 6Ownership of More Than Five Percent on Behalf of Another Person:

 

Not Applicable

 

Item 7Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person:

 

Not Applicable

 

Item 8Identification and Classification of Members of the Group:

 

Not Applicable

 

Item 9Notice of Dissolution of Group:

 

Not Applicable

 

Item 10Certification

 

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.

 

 

 

 

Page 5 of 5

 

Signature

 

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

 

Date: 11/28/2023   By: /s/ Michael Weintraub
        Name:  Michael Weintraub

 

 

 

 

 

 


OptimizeRx (NASDAQ:OPRX)
Historical Stock Chart
From Jan 2024 to Feb 2024 Click Here for more OptimizeRx Charts.
OptimizeRx (NASDAQ:OPRX)
Historical Stock Chart
From Feb 2023 to Feb 2024 Click Here for more OptimizeRx Charts.